Methylene Blue

• 30mL liquid solution
• Tablets
• 10g powder

• Redox cycle as an electron donor and acceptor, bypassing dysfunctional ETC components, especially Complex I and III, in certain models
• Support mitochondrial function by acting as a pseudo NADH oxidase, helping maintain mitochondrial membrane potential and ATP output signals
• Reduce reactive oxygen species formation and protect mitochondrial DNA from oxidative insults in oxidative stress paradigms
• Exhibit weak reversible MAO A inhibition at higher concentrations, with low dose ranges typically below strong MAO related thresholds
• Modulate nitric oxide related pathways by inhibiting NO synthase signaling, relevant to inflammation and vascular tone models

Researchers study Methylene Blue in relation to

• Increased ATP production signals
• Improved mitochondrial respiration metrics
• Enhanced memory retention in animal models
• Reduced oxidative stress markers
• Improved neuronal survival endpoints
• Faster recovery after stress exposure in select paradigms
• Higher baseline cellular energy related measures in some models

Effects reported in studies include: Low-dose use shows high tolerability across most research models.

• Mild gastrointestinal discomfort
• Head pressure
• Insomnia at higher doses
• Agitation in high-redox states
• Serotonergic interaction potential at excessive concentrations
• Urine/fecal discoloration (blue)

Synergistic Combinations in Research Applications Mitochondria / Energy: Neuroprotection / Cognition: Anti-aging: \\\Cautionary Notes\\\ Due to weak MAO-A activity at high doses, researchers avoid combining MB with: Low-dose MB shows minimal interaction risk, which is why it is commonly combined with mitochondrial or neuroprotective peptides in research.

• MOTS-c
• NAD+
• 5-Amino-1MQ
• Humanin
• Dihexa
• Cerebrolysin / Cerebroprotein Hydrolysate
• SS-31
• Semax
• Selank
• Epithalon
• GHK-Cu / GLOW / KLOW
• Crystagen
• Humanin
• High-dose serotonergic compounds
• Strong MAO inhibitors
• High-dose stimulants